Connection
Kurt Stenmark to Anti-Inflammatory Agents
This is a "connection" page, showing publications Kurt Stenmark has written about Anti-Inflammatory Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.373 |
|
|
|
-
Strassheim D, Riddle SR, Burke DL, Geraci MW, Stenmark KR. Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent manner. J Immunol. 2009 Dec 01; 183(11):6981-8.
Score: 0.263
-
Stenmark KR, Rabinovitch M. Emerging therapies for the treatment of pulmonary hypertension. Pediatr Crit Care Med. 2010 Mar; 11(2 Suppl):S85-90.
Score: 0.067
-
Roy RM, Allawzi A, Burns N, Sul C, Rubio V, Graham J, Stenmark K, Nozik ES, Tuder RM, Vohwinkel CU. Lactate produced by alveolar type II cells suppresses inflammatory alveolar macrophages in acute lung injury. FASEB J. 2023 12; 37(12):e23316.
Score: 0.043